Biotechnology firms operate in a highly innovative and capital-intensive environment, characterized by high levels of R&D, long product development periods, significant regulations, and high levels of uncertainty. These firms rely heavily on intangible assets, such as intellectual capital and...

Purpose The purpose of this study is to identify papers that have produced the most significant impact on research on strategic alliances in the biotechnology industry. The authors attempt to illustrate the thematic evolution of its intellectual structure through 616 papers published between...

A sustainable ocean economy, or blue economy, encompasses economic activities utilizing marine resources while prioritizing the long-term health of oceans. While its potential to contribute to Gross Domestic Product (GDP) is acknowledged, limited research explores its specific influence on...

The European Union (EU) is at an important point for developing its industrial biotechnology (IB) sector, as emerging biotechnologies advances merge with traditional industry. This external expert report reviews the EU's IB sector and associated emerging technologies, looking at its strengths,...

This Communication aims to unlock the full benefits of biotechnologies and biomanufacturing, which are crucial for the competitiveness and modernisation of EU industry and offer high growth and productivity potential.